Materials

Q1 2022

Sales in the Materials segment rose considerably compared with the first quarter of 2021. This was mainly driven by the strong sales increase in the Monomers division. The Performance Materials division also recorded considerable growth.

Factors influencing sales in Q1 2022 – Materials

 

Materials

Performance Materials

Monomers

Volumes

3.7%

1.3%

6.1%

Prices

31.4%

19.2%

43.7%

Portfolio

–0.1%

0.0%

–0.2%

Currencies

4.8%

4.5%

5.2%

Sales

39.9%

24.9%

54.9%

Sales performance was largely attributable to higher price levels in both divisions as a result of the increase in raw materials prices. Both divisions raised prices in all business areas.

Currency effects, mainly relating to the Chinese renminbi and the U.S. dollar, also had a positive impact on sales.

Sales growth was also supported by slightly higher volumes on the back of continued strong demand. The Monomers division increased volumes, especially for polyamides in North America and for methylene diphenyl diisocyanate (MDI) in Asia Pacific, North America and Europe. Sales volumes in the Performance Materials division were slightly above the prior-year quarter. This was mainly driven by demand for engineering plastics in Asia and Europe.

The segment’s income from operations (EBIT) before special items rose considerably compared with the prior-year quarter. This was primarily due to considerably higher EBIT before special items in the Monomers division, mainly as a result of price-driven margin growth in the ammonia and polyamide value chains. The Performance Materials division recorded a slight decline in earnings. Slightly higher margins were unable to offset the rise in fixed costs.

Q1 segment data – Materials (Million €)

 

 

2022

2021

+/–

Sales to third parties

 

4,821

3,447

39.9%

of which Performance Materials

 

2,164

1,732

24.9%

Monomers

 

2,657

1,715

54.9%

Income from operations before depreciation, amortization and special items

 

954

863

10.6%

Income from operations before depreciation and amortization (EBITDA)

 

952

843

12.9%

Depreciation and amortizationa

 

203

195

4.0%

Income from operations (EBIT)

 

749

648

15.6%

Special items

 

–2

–24

91.0%

EBIT before special items

 

751

672

11.8%

Assets (March 31)

 

11,921

9,696

23.0%

Investments including acquisitionsb

 

142

105

35.3%

Research and development expenses

 

47

42

12.5%

a

Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)

b

Additions to property, plant and equipment and intangible assets